CClinicalTrials.gg
CompletedNCT07355673Updated Jan 21, 2026

The Influence of Isolation Techniques in Gingival Irritation During an In-office Bleaching

An interventional study of Relative Isolation and Absolute Isolation in Gingival Irritation, sponsored by University of Santiago de Compostela. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by University of Santiago de Compostela · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled May 2025, registered Dec 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this study was to evaluate if two different isolation techniques used during in-office bleaching influence the risk of gingival irritation. The secondary objectives were to investigate whether the isolation technique affects bleaching efficacy, the occurrence of tooth sensitivity, and the intensity of tooth sensitivity (TS).

Read the detailed description
  1. Visit 1: Study information and delivery of informed consent. Recording of patient's medical history, general examination, and prophylaxis. Alginate impressions will be taken of the upper and lower arches for all the patients who meet the inclusion criteria. The impressions will be poured into plaster, and a positioning guide-finder tray will be fabricated for each patient for color measurement.
  2. Visit 2: Initial color measurement with a spectrophotometer and the positioning guide. Two clinicians performed the assigned isolation technique (relative or absolute). Then after a correct isolation the clinicians apply over the buccal surface from premolar to premolar of both arches the bleaching agent (Opalescence Boost 40%, Ultradent Products, South Jordan, USA).Two application of 20 minutes each. Objective examination of gingival tissues was performed visually, documented with photographs, and verified using a periodontal probe. The sensitivity was recorded and patient were given a sensitivity test to record at home. c) Visit 3: One week after the first bleaching session. Color measurement with a spectrophotometer and the positioning guide. In this visit the second bleaching session was done with the same steps as visit 2. d) Visit 4: 15 days after the second bleaching session. Final data collection (color + patients sensitivity test)
02

Conditions studied

  • Gingival Irritation

Keywords

  • Gingival irritation
  • Vital Bleaching
  • In-Office bleaching
  • Isolation
03

In context

Lead sponsor

University of Santiago de Compostela is the lead sponsor of 59 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • No oral os systemic pathology
  • Periodontally Healthy
  • No cavities
  • Tooth shade of the canines A2 or darker

Exclusion criteria

Exclusion Criteria:

  • Adhesive restorations or protheses in the anterior region
  • Enamel or dentin alterations
  • Smoking habits
  • Pregnant women
  • Undergone prior bleaching treatment
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Active comparator
    Relative Isolation

    The relative isolation technique consists in inserting a lip retractor (OptraGate, Ivoclar Vivadent) and applying a gingival barrier resin (OpalDam, Ultradent Products) along the gingival margin, extending approximately 2-3 mm onto the enamel.

    Device: Relative Isolation

  • Experimental
    Absolute isolation

    The total rubber dam isolation was carried out placing the dam (Flexidam non latex; Roeko) from premolar to premolar in both arches and stabilizing it with clamps (B4; Hygenic). Dental silk ligatures were used to achieve proper cervical retraction.

    Device: Absolute Isolation

Interventions

  • DeviceRelative Isolation

    General Examination with bite-wings, dental prophylaxis, alginate impressions of both arches, creation of individualized bleaching trays and position finder trays. . Relative isolation of the gingival tissues. Two applications of the bleaching agent of 20 minutes

  • DeviceAbsolute Isolation

    General Examination with bite-wings, dental prophylaxis, alginate impressions of both arches, creation of individualized bleaching trays and position finder trays. . Absolute isolation of the gingival tissues. Two applications of the bleaching agent of 20 minutes

06

What researchers measure

Primary outcomes

  1. Gingival Evaluation Recording

    Objective examination of gingival tissues was performed visually, documented with photographs, and verified using a periodontal probe. Patients were classified according to the Löe and Silness' gingival index as follows: G0 =normal gingiva; G1=mild inflammation (slight color change, slight edema, no bleeding on probing); G2=moderate inflammation (redness, edema, glazing, bleeding on probing); and G3=severe inflammation (marked redness and edema, ulceration, spontaneous bleeding).

    Time frame: -15 minutes after the first bleaching session - 15 minutes after the second bleaching session

Secondary outcomes

  1. Questionary of dental sensitivity

    General tooth sensitivity was assessed using a 5-point Numeric Rating Scale (NRS), where 0 = no sensitivity; 1 = mild discomfort; 2 = moderate discomfort that does not interfere with daily activities; 3 = considerable discomfort leading to avoidance of certain foods and beverages; and 4 = severe sensitivity requiring interruption of the bleaching treatment. Participants selected the numeric value that best represented their perceived level of tooth sensitivity. Pain intensity was recorded at the following time points: * Perioperative * 1 hour postoperatively * 24 hours postoperatively * 48 hours postoperatively

    Time frame: Perioperative , 1 hour postoperative, 24 hours postoperative, 48 hours postoperative.

  2. Shade evaluation of each patient

    Tooth color will be measured using a dental spectrophotometer, recording the following parameters: L (lightness, representing the shade from black to white on a scale of 0 to 100), a (color variation along the red-green axis, with positive values toward red/purple and negative values toward green/blue), b (color variation along the yellow-blue axis, with positive values toward yellow and negative values toward blue/purple), C (chroma, describing the intensity or saturation of a color, expressed on a scale from 0 to 40, where 0 indicates no saturation and 40 the maximum saturation), and hº (hue, representing the dominant wavelength of a color on a continuous circular scale from 0° to 360°). Color changes between visits will be calculated using the CIELab, CIEDE2000, and White Index for Dentistry (WID) formulas. Color measurements will be recorded at the following time points: Baseline (Bleaching Day 1) One week after baseline (Before Bleaching Day 2) Follow-up (One week after)

    Time frame: Baseline, Before the first bleaching session, Revision (1 week after the 2 bleaching session)

07

Study locations

1 site
  • School of Medicine and Dentistry
    Santiago de Compostela, A Coruña 15705, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07355673
Lead sponsor
University of Santiago de Compostela
Responsible party
Patricia Pereira-Lores (Principal Investigator, University of Santiago de Compostela) — Principal investigator
First posted
Jan 21, 2026
Start date
May 15, 2025
Primary completion
Jul 16, 2025
Completion
Jul 16, 2025
Last update
Jan 21, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion